Brazil · Delayed Price · Currency is BRL MBRF Global Foods Company Earnings Call Transcripts
Fiscal Year 2026
-
Record Q2 sales and EBITDA growth were driven by strong performance across all segments, with notable gains in BRF and South America. Despite high leverage and negative free cash flow due to CapEx and working capital, management expects improved cash conversion and margin recovery in H2, supported by new export licenses and ongoing synergies.
-
Net sales rose 6.9% year-over-year in Q1, driven by strong global demand for beef and poultry, though margins were pressured by high cattle costs and inventory build-up due to geopolitical events. Management expects improved results and normalized inventory by year-end.
Fiscal Year 2025
-
Record net revenue and volume growth in 2025 were driven by capacity expansion, value-added products, and strong international demand. Operational efficiency, M&A, and disciplined capital allocation supported robust margins and cash flow, with synergies and further growth expected in 2026.
-
Q3 2025 saw record EBITDA and net income, driven by strong international operations, processed food growth, and successful merger synergies. Market diversification and sustainability initiatives mitigated risks from avian flu and export restrictions, while capital discipline and expanded buybacks supported shareholder value.
-
Q2 2025 delivered 8.6% revenue growth and improved margins, with strong South America and BRF performance offsetting North America margin pressure. The Marfrig-BRF merger is on track, with synergy capture and financial discipline as key priorities.
-
Q1 2025 saw 27% revenue growth and improved margins, with strong South American and BRF performance offsetting North American cost pressures. The proposed Marfrig-BRF merger aims to unlock BRL 805 million in annual synergies and create a leading global food company.
Fiscal Year 2024
-
Q4 2024 saw net revenue rise 22% year-over-year to BRL 41.3 billion, with adjusted EBITDA up 59% for the year. Leverage fell to 2.47x, and strong cash flow enabled high dividend payouts and debt reduction. Market and product diversification, plus operational efficiency, drove robust results.
-
Q3 2024 saw double-digit revenue and EBITDA growth, positive net income, and strong free cash flow, driven by diversification and robust demand across regions. Leverage declined, dividends were reinstated, and asset sales boosted liquidity, supporting continued investment and optimism for 2025.
-
Q2 2024 saw 16.5% revenue growth and a 64.8% EBITDA increase, with net income turning positive. North America faced margin pressure, while South America and BRF drove strong results. Deleveraging continues, and BRF may pay dividends in November.